American Headache Society

After reflecting on the significant achievements and growth of the AHS, the Board of Directors are pleased to share the updated Society Strategic Imperatives which will help guide AHS activities and efforts and showcase the outstanding goals and accomplishments of AHS members and volunteer leaders. From Dr. Todd J. Schwedt, AHS President: "Together, I am confident that we can harness the current momentum and channel it towards realizing these goals. Please share your thoughts as we advance each of these imperatives during the coming years." View the Society's Strategic Imperatives on the AHS website here: bit.ly/3NaQlG6

Time is running out to apply to the 2024 AHS Emerging Leaders Program! #EmergingAHS aims to encourage early-career medical professionals to enter and thrive not only in the field of headache medicine but also within the Society. To apply, candidates should be AHS members in good standing for at least 1 year, be within 7 years of having completed a training program or terminal research degree, and commit to attending the 2024 Scottsdale Headache Symposium® and 67th Annual Scientific Meeting in person (expenses paid), as well as a virtual mid-year training forum. Learn more and apply by September 1st here: bit.ly/46w5FF7

Early-bird registration is now open to all for the 2024 Scottsdale Headache Symposium! Join us for practical, clinical, evidence-based information on the diagnosis, management and treatment of #headache disorders. Click the link to register and secure your hotel accommodations today: #MedEd #Neurology #AHSAZ

#HeadacheHighlight Plain Language Summary: Post-traumatic headache (PTH) following concussion is a common and potentially disabling condition impacting youth, yet there are no standards for treatment. This article reviews current evidence and identifies knowledge gaps to guide future research. Based on the limited available evidence and expert opinion, we offer a roadmap for the treatment of PTH in children. View the full Headache Journal (Headache: The Journal of Head & Face Pain) article here: bit.ly/3Wzzikf

Congratulations to all Fellows and programs who participated this year in #HeadacheMatch 2024! Are you interested in Headache Medicine? The AHS National Headache Medicine Fellowship website serves as a valuable resource for fellowship applicants to find information about current training programs with available openings. Click the link to learn more: bit.ly/3Vh4pQ2 #FellowMatch #HeadacheMedicine

AHS members, exclusive early-bird registration for the 2024 Scottsdale Headache Symposium is now available! Join us November 14-17 in Scottsdale, AZ, or live-stream from your home or office and earn AMA PRA Category 1 Credits™. Experience lectures, panel discussions, case-based presentations, and hands-on demonstrations that you can bring back home and apply to clinical practice. Register today to receive an access code to secure the discounted room rate here: bit.ly/4dpZGUx #MedEd #Neurology #AHSAZ

Registration is open for the next Live Q&A session of the NEW Mastering Migraine Therapies program. The virtual session will be held Wednesday, September 11 at 7:00 PM ET via AHS Education On Demand. Designed to enhance the MMT program, this hour-long webinar will answer your burning questions from the sessions you watched via Education On Demand. Join expert faculty in headache medicine and enhance your headache knowledge all while earning AMA Category 1 Credit™. Learn more here: bit.ly/46nyHXl #AHSMasteringMigraine

#HeadacheHighlights Plain Language Summary: “In this open-label study, we looked at the effects of eptinezumab in a subset of patients with chronic migraine and medication-overuse headache (MOH). Our results showed that after 2 years of treatment with eptinezumab, these patients reported that their headache days had decreased by more than half, their headaches were less severe, and that headaches interfered much less with their lives. Eptinezumab preventive therapy in patients with chronic migraine showed benefits for the group of patients with MOH.” View the full Headache Journal (Headache: The Journal of Head & Face Pain) study here: bit.ly/3SBuHNl

For July, we are excited to feature recent Fellow, Dr. Ali Tavasoli who completed his first year as a fellow at Barrow Neurological Institute at Phoenix Children’s Hospital. Dr. Tavasoli became interested in headache medicine after “actively participating in a research project focusing on the preventive efficacy of Cinnarizine in pediatric migraine. “ and says, “The results have been surprising, revealing significant changes that healthcare providers can implement in the Quality of Life for pediatric migraine patients. This outcome has motivated me to deepen my involvement in pediatric headache medicine, as I am eager to contribute further to the field and enhance patient care.” Learn more about Dr. Tavasoli here: bit.ly/46s76Ej

We are excited to announce that nominations for awards to be presented during the 2024 Scottsdale Headache Symposium are now open. AHS members should complete a separate nomination form for each nominee and award being submitted. Learn more about each award and nominate a candidate by Monday, August 12, 2024: bit.ly/3WxUzf7